Good returns from Viropharma Inc. (VPHM). On October 16, 2007 VPHM looked attractive at 9.57; today at 13.80 that investment shows a 44% gain in just under 12 months.
I'm happy with these results especially in rough markets. At this time, I don't see much upside potential, time to sell.
.
Disclaimer: The opinions in this blog are not to be taken as recommendations to buy or sell any of the securities mentioned. If you choose to invest, you are doing it at your own risk.
Showing posts with label VPHM. Show all posts
Showing posts with label VPHM. Show all posts
Thursday, September 25, 2008
Tuesday, October 16, 2007
A Look at VPHM
Painful days in the investment world, a reminder of October '87. It might be time to position some funds into out-of-favor stocks.
ViroPharma Inc. (VPHM), selling at 9.57, seems to be holding up well in somewhat sad market conditions.
ViroPharma Incorporated is a bio pharmaceutical company, which engages in the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings in the United States.
I see some positive characteristics that could signify a favorable move in the stock price, high average daily volume, may close today above its 50 day moving average (9.49), increased fund ownership over the past few weeks, stock at 48% below the 52 week high, low P/E ratio (7) and a reasonable book value of 1.58 have made this company worth looking at.
ViroPharma Inc. (VPHM), selling at 9.57, seems to be holding up well in somewhat sad market conditions.
ViroPharma Incorporated is a bio pharmaceutical company, which engages in the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings in the United States.
I see some positive characteristics that could signify a favorable move in the stock price, high average daily volume, may close today above its 50 day moving average (9.49), increased fund ownership over the past few weeks, stock at 48% below the 52 week high, low P/E ratio (7) and a reasonable book value of 1.58 have made this company worth looking at.
Labels:
investments,
markets,
recommendations,
stock market,
stock picks,
stock research,
stocks,
ViroPharma Inc,
VPHM
Subscribe to:
Posts (Atom)